{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:35Z","timestamp":1789924775848,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2014GXNSFAA118262"],"award-info":[{"award-number":["2014GXNSFAA118262"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["Z2007084"],"award-info":[{"award-number":["Z2007084"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Committee of Science and Technology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jneuroim.2018.03.021","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T10:02:27Z","timestamp":1522836147000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells"],"prefix":"10.1016","volume":"320","author":[{"given":"Jinpin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuean","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.03.021_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12935-017-0401-2","article-title":"Transactivation of the estrogen receptor promoter by BRCA1","volume":"17","author":"Archey","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/eje.0.1500225","article-title":"The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases","volume":"150","author":"Aust","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of \"innate autoimmunity\"","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0b013e328357a829","article-title":"Autoimmune mechanisms in myasthenia gravis","volume":"25","author":"Cavalcante","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0035","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1073\/pnas.1520112113","article-title":"CXCL13 is a plasma biomarker of germinal center activity","volume":"113","author":"Havenar-Daughton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mrrev.2014.10.002","article-title":"Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis","volume":"763","author":"Hecker","year":"2015","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0045","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1158\/0008-5472.CAN-13-3279","article-title":"Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene","volume":"74","author":"Hu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","article-title":"Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells","volume":"14","author":"Jiang","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0060","first-page":"11","article-title":"NEAT1 is required for survival of breast Cancer cells through FUS and miR-548","volume":"10","author":"Ke","year":"2016","journal-title":"Gene Regul. Syst. Biol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2016.02.005","article-title":"Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells","volume":"172","author":"Li","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/679563","article-title":"Genome-wide analysis of mir-548 gene family reveals evolutionary and functional implications","volume":"2012","author":"Liang","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00432-014-1836-7","article-title":"microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway","volume":"141","author":"Liu","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0085","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1039\/c6ib00128a","article-title":"Quantitative analysis of B-lymphocyte migration directed by CXCL13","volume":"8","author":"Liu","year":"2016","journal-title":"Integr. Biol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0100","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0105","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","article-title":"Expression of microRNA-146 in rheumatoid arthritis synovial tissue","volume":"58","author":"Nakasa","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","article-title":"Physiological and pathological roles for microRNAs in the immune system","volume":"10","author":"O'Connell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2015.07.027","article-title":"MiR-548-3p functions as an anti-oncogenic regulator in breast cancer","volume":"75","author":"Shi","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0120","doi-asserted-by":"crossref","first-page":"21676","DOI":"10.18632\/oncotarget.7866","article-title":"Analysis of plasma microRNA expression profiles revealed different cancer susceptibility in healthy young adult smokers and middle-aged smokers","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2010.02.013","article-title":"Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia","volume":"221","author":"Shiao","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0130","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0135","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/1521-4141(200105)31:5<1544::AID-IMMU1544>3.0.CO;2-I","article-title":"BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo","volume":"31","author":"Vissers","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0140","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.18632\/oncotarget.6885","article-title":"Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis","volume":"7","author":"Weiss","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-007-7355-9","article-title":"Functional aspects of animal microRNAs","volume":"65","author":"Williams","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0150","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.3390\/ijms150814411","article-title":"MiRNA-548ah, a potential molecule associated with transition from immune tolerance to immune activation of chronic hepatitis B","volume":"15","author":"Xing","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2011.09.037","article-title":"Different molecular expression in thymoma with ocular or generalized myasthenia gravis","volume":"313","author":"Zhang","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12031-013-9976-9","article-title":"Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis","volume":"50","author":"Zhang","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2018.03.021_bb0165","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00109-013-1043-z","article-title":"MicroRNA in immunity and autoimmunity","volume":"91","author":"Zhu","year":"2013","journal-title":"J. Mol. Med. (Berl)"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818301668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818301668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:32:05Z","timestamp":1759048325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818301668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":33,"alternative-id":["S0165572818301668"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.03.021","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}